- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Malleoli.
Displaying page 1 of 1.
EudraCT Number: 2005-005754-50 | Sponsor Protocol Number: SBG-1-12 | Start Date*: 2006-07-20 |
Sponsor Name:Biotec Pharmacon ASA | ||
Full Title: A randomised, double-blind, placebo-controlled study to determine the efficacy of soluble beta-1,3/1,6-glucan in chronic foot ulcers in diabetes | ||
Medical condition: Chronic foot ulcers in diabetes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003915-30 | Sponsor Protocol Number: MT4VLU07/A-V7 | Start Date*: 2008-05-15 |
Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust | ||
Full Title: The efficacy of maggots as a debridement agent for venous leg ulcers | ||
Medical condition: The purpose of the trial is to evaluate the effectiveness of BioFOAM maggots in achieving rapid debridement of chronic venous leg ulcers. Removal of slough and necrotic tissue from these wounds is ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003636-38 | Sponsor Protocol Number: SBG-1-13 | Start Date*: 2008-09-22 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: Estudio aleatorizado, doble ciego, controlado con placebo para evaluar la eficacia y seguridad de beta-1,3/1,6- glucano soluble (SBG) en úlceras crónicas del pie en pacientes con diabetes. A random... | |||||||||||||
Medical condition: Úlceras crónicas del pie en pacientes con diabetes Chronic foot ulcers in patients with diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005775-34 | Sponsor Protocol Number: TJ16042008G | Start Date*: 2009-01-16 |
Sponsor Name:ZooBiotic Limited | ||
Full Title: A Randomised Controlled Trial of Larval Therapy in the Debridement of Leg Ulcers. | ||
Medical condition: The purpose of the trial is to evaluate the effectiveness of the BioFOAM dressing in achieving rapid debridement of chronic wounds typified by leg ulcers. Removal of slough and necrotic tissue fro... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002100-41 | Sponsor Protocol Number: LL-37001B | Start Date*: 2012-07-12 | |||||||||||
Sponsor Name:Lipopeptide AB | |||||||||||||
Full Title: A double-blind, randomized, placebo-controlled, safety and pilot dose-response study of LL-37 in hard-to-heal venous leg ulcers | |||||||||||||
Medical condition: Hard-to-heal (HTH) venous leg ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000536-10 | Sponsor Protocol Number: LL-37002 | Start Date*: 2018-08-13 | |||||||||||
Sponsor Name:Promore Pharma AB | |||||||||||||
Full Title: A Study in Patients with Hard-to-Heal Venous Leg Ulcers to Measure Efficacy and Safety of Locally Administered LL-37; A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre Trial | |||||||||||||
Medical condition: Hard-to-Heal (HTH) venous leg ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003765-10 | Sponsor Protocol Number: I-Tackle | Start Date*: 2018-07-10 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: Immunotherapy Followed By EGFR Inhibitor In Locally Advanced Or Metastatic Squamous Cell Cancer Of The Skin: Tackling Primary And Secondary Resistance | |||||||||||||
Medical condition: Patient with Locally Advanced Or Metastatic Squamous Cell Cancer Of The Skin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005532-18 | Sponsor Protocol Number: PLX-CLI-03 | Start Date*: 2017-01-02 | |||||||||||
Sponsor Name:Pluristem Ltd. | |||||||||||||
Full Title: A Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Phase III Study to Evaluate the Efficacy, Tolerability and Safety of Intramuscular Injections of PLX-PAD for the Treatmen... | |||||||||||||
Medical condition: Critical Limb Ischemia (CLI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) CZ (Prematurely Ended) AT (Completed) HU (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003417-19 | Sponsor Protocol Number: BN42644 | Start Date*: 2022-01-03 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:F. HOFFMANN - LA ROCHE LTD. | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A TWO-PART, SEAMLESS, MULTI-CENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND EFFICACY OF RO7204239 IN COMBI... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Spinal Muscular Atrophy (SMA) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IT (Trial now transitioned) PL (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) PT (Trial now transitioned) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022518-16 | Sponsor Protocol Number: KADFUT | Start Date*: 2011-07-13 | ||||||||||||||||
Sponsor Name:King's College Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: A prospective single blind randomised controlled study to compare the outcomes of patients with diabetes and clinically non-infected ischaemic and neuropathic foot ulcers treated with and without ... | ||||||||||||||||||
Medical condition: foot ulcers with no clinical signs of infection in patients with diabetes. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
